dopamine
Showing 1 - 25 of 2,264
Stress Response Trial (tDCS actif, tDCS Sham)
Not yet recruiting
- Stress Response
- tDCS actif
- tDCS Sham
- (no location specified)
Apr 20, 2023
Septic Shock Trial in Chicago (Dopamine, Norepinephrine)
Completed
- Septic Shock
- Dopamine
- Norepinephrine
-
Chicago, IllinoisRUSH University Medical Center
Dec 15, 2022
Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain
Suspended
- Cocaine Abuse
- Brain Dopamine Reactivity
- Brain Dopamine Receptor
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
The Meaning of Dopaminergic Pathway in Sleep Breathing
Enrolling by invitation
- Sleep Apnea
- Sleep-Disordered Breathing
- Polysomnography
- +2 more
-
Wroclaw, PolandWroclaw Medical Uniwesity
May 25, 2023
Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- L-dopa/Carbidopa
- Placebo
- (no location specified)
Jun 11, 2023
Schizophrenia Trial in Changsha (Theta burst stimulation)
Not yet recruiting
- Schizophrenia
- Theta burst stimulation
-
Changsha, Hunan, ChinaCentral South University
Jul 3, 2022
Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)
Recruiting
- Parkinson Disease
- A-dopamine
- optimized oral treatment
-
Lille, FranceHopital Roger Salengro, CHU Lille
Oct 11, 2022
Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)
Not yet recruiting
- Neurosciences
- Précurseur de la dopamine
- +2 more
- (no location specified)
Feb 1, 2023
Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)
Recruiting
- Chronic Pain
- Methylphenidate
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 9, 2023
Bipolar Depression Trial in New York (Cariprazine)
Not yet recruiting
- Bipolar Depression
-
New York, New YorkColumbia University Medical Center
Jan 23, 2023
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Dopamine Receptor Binding in Treatment Resistant Depression
Not yet recruiting
- Treatment Resistant Depression
- PET scans
- (no location specified)
Nov 9, 2022
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Idiopathic Parkinson's Progression and Dopamine Transporter
Completed
- Parkinson Disease
- Ioflupane I 123
-
Lexington, KentuckyUniversity of Kentucky Department of Neurology
Nov 16, 2022
Obesity, Healthy Volunteers, Overweight Trial run by the NIDDK ([c11] raclopride, [18F]fallypride)
Active, not recruiting
- Obesity
- +2 more
- [c11] raclopride
- [18F]fallypride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 30, 2022
Effect and Mechanism of Dopamine on Ulcerative Colitis
Recruiting
- Dopamine Dysregulation Syndrome
- Ulcerative Colitis
- Patients diagnosed with ulcerative colitis
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Feb 28, 2022
Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)
Recruiting
- Health
- Dopamine
- +5 more
-
Edmonton, Alberta, CanadaClinical Physiology Research Laboratory
Apr 6, 2022
Parkinson Disease Trial in Seoul (A9-DPC)
Recruiting
- Parkinson Disease
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 24, 2023
Shock Hypovolemic, Shock, Septic, Blood Transfusion Trial in Dhaka (Dopamine, adrenaline, Blood Transfusion)
Recruiting
- Shock Hypovolemic
- +4 more
- Dopamine
- +2 more
-
Dhaka, BangladeshIcddr,B
Dec 18, 2022
Functional Relevance of Dopamine Receptors in Healthy Controls
Recruiting
- Schizoaffective Disorder
- Schizophrenia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Obesity Trial in Busan (Glucose injection/Normal saline injection)
Completed
- Obesity
- Glucose injection/Normal saline injection
-
Busan, Korea, Republic ofPusan National University Hospital
Apr 19, 2022
Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)
Enrolling by invitation
- Dopamine D2/3 Receptor Availability
- +2 more
- Varenicline
- Placebo
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Mar 2, 2022
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023